Envoy Medical, Inc.
Envoy Medical, Inc. scores highest on Nitro (72) and lowest on Price (5). Its PosiPenta is 44.88 out of 100, around the middle of similar companies.
On the Penta Grid this week, Envoy Medical, Inc. is Grid #387 of 837 in the Healthcare sector in United States, and Grid #2,426 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Envoy Medical, Inc. | 44.88 | 5 | 60 | 72 | 41 | 45 |
| ImageneBio, Inc. | 40.29 | 48 | 19 | 32 | 53 | 49 |
| TELA Bio, Inc. | 32.25 | 0 | 53 | 66 | 2 | 41 |
| SANUWAVE Health, Inc. | 26.24 | 34 | 43 | 20 | 3 | 32 |
| Precision Optics Corporation, Inc. | 55.61 | 25 | 73 | 65 | 53 | 61 |
| LeonaBio, Inc. | 30.10 | 33 | 4 | 43 | 39 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.88 |
| P/B ratio | 13.96 |
EEarnings
| Trailing EPS | ₹-71.98 |
| Forward EPS | ₹-22.42 |
NNitro
| Price | 63.27 |
| 52-week high | 90.36 |
| 52-week low | 34.38 |
| Fall from 52-week high | 30.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.22 |
AAnchor
| Beta (price swings) | 1.95 |
| Market cap | ₹488 Cr |
| Insider holding | 40.23% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Envoy Medical, Inc.'s PosiPenta score?
Envoy Medical, Inc.'s PosiPenta is 44.88 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Envoy Medical, Inc. stand on the Penta Grid?
On the Penta Grid this week, Envoy Medical, Inc. is Grid #387 of 837 in the Healthcare sector in United States, and Grid #2,426 of 4,000 in United States.
Which PosiPenta pillar is strongest for Envoy Medical, Inc.?
Nitro (momentum), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Envoy Medical, Inc.?
Price (valuation), with a score of 5 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.